BTAX (Biostax) Risk Assessment

View and export this data going back to . Start your Free Trial

What is Biostax Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Biostax is: No Data: Cannot be evaluated.

Competitive Comparison of Biostax's Risk Assessment

For the Biotechnology subindustry, Biostax's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biostax's Risk Assessment Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biostax's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Biostax's Risk Assessment falls into.

Save Embed

;

Save Embed

;

Biostax (OTCPK:BTAX) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Biostax Risk Assessment Related Terms

Thank you for viewing the detailed overview of Biostax's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Biostax Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biostax Corp (OTCPK:BTAX) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

2431 Aloma Avenue, Suite 124, Winter Park, FL, USA, 32792

Website

https://www.biostaxcorp.com

Biostax Corp is a biotechnology company utilizing the Biostax Development Engine, is a developer and marketer of pharmaceutical, biotechnology and MedTech products that have a well-defined path to market. The company is focused on driving the development and commercialization of proprietary mechanisms to prevent, intercept and improve these diseases at affordable cost. It is a therapeutic and health tech agnostic, constantly seeking assets with low acquisition costs and high growth opportunities having significant clinical and commercial potential.

Executives

Glen A Farmer	officer: Chief Financial Officer	20358 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
H. Louis Salomonsky Jr. Revocable Trust	10 percent owner	2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792
Henry Louis Salomonsky	director, 10 percent owner	2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792
Kelly O'brien Wilson	10 percent owner, officer: COO and ICEO and IP	2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792
James Norman Curley	other: Member of 10% owner group	410 DAHLIA AVE, CORONA DEL MAR CA 92625
Empower Insurance Corp Ltd	other: Member of 10% owner group	1254 LEEWARD HIGHWAY, 4 CARIBBEAN PLACE, PROVIDENCIALES W7 TKCA1ZZ
Global Reverb Corp	10 percent owner, other: Member of 10% owner group	100 S EOLA DR, UNIT 1703, ORLANDO FL 32801
Paul Puskadi	other: Member of 10% owner group	2020 TIGERTAIL BLVD, 7A, DANIA BEACH FL 33004
Deane Rhodes	other: Member of 10% owner group	9200 HALSEY CIRCLE NE, TUSCALOOSA AL 35406
Roger Dale Bozarth	other: Member of 10% owner group	9028 GREAT HERON CIR, ORLANDO FL 32836
Joel Yanowitz	other: Member of 10% owner group	100 TAMAL PLZ, SUITE 106, CORTE MADERA CA 94925
Rogoff Family Trust Dtd	other: Member of 10% owner group	20701 N SCOTTSDALE DR, ST 107-501, SCOTTSDALE AZ 85255
George Sasko	other: Member of 10% owner group	515 WESTCHESTER DR, STE D, CAMPBELL CA 95008
Raster Investments, Inc	other: Member of 10% owner group	2384 ORCHARD CREST BLVD, MANASQUAN NJ 08736
Robert Jackman Dailey	other: Member of 10% owner group	401 FIRST STREET, LOS ALTOS CA 94022